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Abstract 
The annual meeting of the European Association of Cardiovascular Imaging, EuroEcho-
Imaging, was held in Lisbon, Portugal, in December 2017. In the present paper, we present a 
summary of the ‘Highlights’ session. 
 
Key words: heart failure, heart valve disease, new technologies, congenital heart disease, 
nuclear cardiology, cardiac computed tomography, cardiac magnetic resonance 
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The twenty-first annual scientific meeting of the European Association of Cardiovascular 
Imaging (EACVI), EuroEcho-Imaging 2017, was held in December in Lisbon, Portugal. The 
main themes were “Imaging in heart failure” and “interventional imaging”. 
The meeting was a great success with the highest number of participants ever with 3 973 
delegates and over 1 414 abstracts and clinical cases submitted. 
Overall, 128 abstracts and clinical cases were accepted as oral presentation, 86 moderated 
posters and 985 posters were presented. Of note, the preferred topics regarding abstracts 
submission were “Assessment of morphology and function”, “Heart valves”, “Tissue Doppler 
and speckle tracking”, “Cardiomyopathies” and  “Systemic diseases and other conditions”.       
The ‘Highlights’ session wrapped up the event with a summary of the most relevant abstracts 
presented throughout the congress on the last day of the meeting. A short report of this session 
is presented below. 
Heart Failure 
Reis et al.1 investigated gender-correlated differences in a population with hypertrophic 
cardiomyopathy (HCM) in a Portuguese multicentre study. They included 567 HCM patients 
from 12 hospitals and followed them for 8.0±6.1 years. While women with HCM were older 
and more symptomatic than males, there were no differences in progression to chronic heart 
failure, medical treatment, implantation of intra cardiac defibrillator (ICD), arrhythmias, 
HCM-related mortality, risk of sudden death, stroke and all-cause mortality. Therefore, unlike 
previous studies, in this study, female gender was not associated with a worse prognosis 
The value of the CHA2DS2-VASc risk score and modified Fabry-specific score were studied 
by Hu et al.2 aiming to predict new-onset or recurrent stroke/transient ischemic attack (TIA) 
in patients with Fabry disease without atrial fibrillation. They included 159 patients with 
Fabry disease. During 5 years of follow up, 10% had new onset or recurrent stroke. Risk 
factors were prior stroke, angiokeratoma, creatinine ≥1 mg/dl, left ventricular posterior wall 
diameter >14mm and global longitudinal strain worse than -13.5%. The Fabry-specific score 
based on these risk factors was superior to classic CHA2DS2-VASc risk score on predicting 
new-onset or recurrent stroke/TIA and could potentially help decisions on anticoagulation 
therapy in patients with Fabry.  
Stampfli et al.3 studied patients with left ventricular non-compaction cardiomyopathy (LVNC) 
with focus on right ventricular morphology and function. By CMR, they compared 20 LVNC 
patients with 20 controls and found more trabeculation in the right ventricle (RV) by CMR in 
patients compared to healthy. Also amount of RV and LV trabeculation correlated closely in 
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LVNC patients. These findings suggest that LVNC is a biventricular disease, morphologically 
affecting both LV and RV to a similar extent. 
Lie et al.4 presented echocardiographic parameters to predict life-threatening ventricular 
arrhythmia in patients with arrhythmogenic cardiomyopathy (AC). In a prospective cohort of 
167 AC patients without previous arrhythmias, 15% had life threatening arrhythmias during 
4.2 years of follow up. The LV mechanical dispersion and RV global strain were the best 
predictors for ventricular arrhythmias. Presence of both risk markers included a 50% risk of 
ventricular arrhythmias within 2 years and could be helpful in decisions on primary 
prevention ICD implantation (Figure 1).  
In a population of 316 patients with heart transplant of which 17 patients suffered from severe 
rejection, Cordeiro et al.5 found that those with severe humoral rejection showed a worsening 
in global longitudinal and circumferential strain before rejection. In contrast, patients with 
cellular rejection did not. Therefore, global strain assessment by echocardiography may allow 
an early detection of a developing humoral graft rejection.  
Dobutamine stress echocardiography was performed by Tereshina et al.6 in 27 patients with 
chemotherapy-induced LV dysfunction and they followed the patients for 1 year. Absence of 
contractile reserve by dobutamine stress echocardiography was associated with a higher risk 
of further progression of ventricular dysfunction. 
Clerc et al.7 performed a direct comparison of single-photon emission computed tomography 
(SPECT), coronary artery calcium score (CACS), coronary CT angiography (CCTA), 
combined SPECT+CACS and hybrid SPECT/CCTA for long-term prediction of major 
cardiac events. They followed 380 patients for 6.3 years. Framingham risk score and SPECT 
were inferior risk markers compared to the other tested modalities. The CCTA and CACS 
score had highest predictive values for major cardiac events.  
 
New technologies 
Regional left ventricular (LV) myocardial work can be assessed non-invasively by pressure-
strain loops (PSL) using speckle-tracking echocardiography (STE). Galli et al.8 used PSL to 
measure constructive and wasted work (CW and WW) in 97 left bundle branch block (LBBB) 
patients undergoing cardiac resynchronization therapy (CRT). At univariate analyses, they 
showed that CW and WW, as well as other standard echocardiographic parameters were 
predictors of CRT response. In multivariable analysis, the addition of CW and WW led to a 
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significant increase in the model prediction, suggesting that PSL analysis might be a 
promising tool for assessing CRT candidates. 
In an experimental study, Aalen et al.9 found that moderate elevation of afterload in 11 
patients with isolated LBBB caused marked reduction in septal work. If confirmed, these 
preliminary findings could have implications for blood pressure evaluation and treatment 
goals in CRT candidates. 
Klæboe et al.10 used 3D echocardiography (3DE) and STE to compare LV geometry and 
function in 20 patients with hypertrophic cardiomyopathy (HCM) genotype positive with mild 
phenotype (LV wall thickness 12-16 mm) versus 30 competitive athletes with similar LV 
mass and ejection fraction. Despite having similar values of global longitudinal strain, the 
HCM patients had smaller 3DE LV volumes and more pronounced mechanical dispersion 
(MD), a cut-off value of MD ≥ 44ms optimally discriminating patients from athletes. 
Rodríguez-Zanella et al.11 assessed the value of LV MD to predict the risk of severe 
arrhythmias and sudden death in 96 patients with structural heart disease followed for 44±20 
months. Using a recently described limit of normality of MD ≥56ms, the authors found that 
that MD is a powerful independent predictor of major arrhythmic events, and allows 
additional prognostic stratification in patients with LV ejection fraction (EF) >35% (Figure 
2). 
Mirea O et al.12 compared the accuracy of STE algorithms from 8 different vendors to identify 
scarred myocardium in 58 patients with previous myocardial infarction. They found that post-
systolic strain index enables to discriminate among segments with transmural, non-transmural 
and no scar, however there were significant differences in the accuracy of different 
algorithms, suggesting need of further standardization from EACVI/ASE/Industry TaskForce 
to achieve interchangeable results among different vendors. 
The RV EF assessed by 3DE has been demonstrated to be a significant predictor of all-cause 
mortality in an unselected cohort of 297 patients with various cardiovascular diseases follow-
up during 3.7±1.1 year by Prevedello et al.13 The RV EF was superior to conventional RV 
functional parameters for predicting outcome. 
Using 3DE in 18 patients before and after mitral valve surgery, Lakatos et al.14 demonstrated 
a marked decrease in RV longitudinal shortening after surgery, with a compensatory increase 
in RV radial function (“bellows” effect) to preserve RV stroke volume and EF. 
In patients with pulmonary hypertension, Palumbo et al.15 found that interventricular septum 
curvature quantified by 3DE had a strong positive correlation with pulmonary arterial 
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pressure. These studies highlight the potential of 3DE to provide a better outcome 
stratification and understanding of RV function. 
 
Heart valve diseases 
Contemporary data on outcome after isolated tricuspid valve surgery (ITVS), was provided 
based on a large nationwide population including all patients undergoing this procedure in 
France from 2013-201416. Among 241 patients undergoing ITVS, in-hospital mortality was 
10%, the combined end-point of death, need for dialysis and ECMO occurred in 19% and 
there was a mean hospitalization duration of 26 days. Congestive heart failure at presentation 
was the sole factor associated with in-hospital mortality, suggesting that patients should be 
referred for ITVS before the development of RV failure. 
Fries et al.17 presented 10 years follow-up data based on a previous described cohort of 58 
patients with severe aortic stenosis (AS) who underwent a myocardial biopsy during aortic 
valve replacement (AVR) and no signs of coronary disease. Patients with severe fibrosis did 
not improve symptoms and 74% died after 10 years, underlining the impact of fibrosis on 
outcome in AS. Future studies should be conducted to demonstrate if AVR before the 
development of fibrosis may improve outcome. 
The clinical importance of pressure recovery in patients with AS was studied in 111 patients 
with asymptomatic severe AS and LVEF>50%18. One fourth of patients had a pressure 
recovery ≥20mmHg. Patients likely to experience pressure recovery, e.g. aorta 
diameter<30mm and ratio of effective orifice area to aorta diameter>0.2cm, had a better 
prognosis in terms of AVR and all-cause mortality. These findings need to be corroborated in 
future studies. 
Paravalvular leakage (PVL) is a strong marker of outcome in patients with AS undergoing 
TAVR. Among 147 patients undergoing TAVR Sanchis et al.19 demonstrated that patients 
with moderate-severe PVL had larger LV septal-bulge height compared to those with mild 
PVL (3.6±1.2 vs. 5.2±1.6mm, p<0.001), despite demonstrating similar septal wall-thickness. 
This was particularly prevalent among patients treated with supra-annular self-expanding 
prosthesis. 
The accuracy of CT aortic valve calcium (AVC) score in determining calcium concentration 
in patients with severe AS, was studied in 69 explanted valves20. The valves were CT-scanned 
ex-vivo and later dissolved into an acid solution in order to calculate calcium concentration. A 
modest correlation (r2=0.62) was demonstrated between AVC and valvular calcium 
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concentration, suggesting that AVC is more dependent of the total calcium amount rather than 
valvular calcium concentration.  
The recently proposed algorithms by the American Society of Echocardiography for grading 
aortic regurgitation (AR) and mitral regurgitation (MR) were tested in two separate studies21-
22. Forty-five patients with AR underwent cardiac magnetic resonance (CMR) study and a 
transthoracic echocardiography (TTE), simultaneously. The algorithm demonstrated a 
sensitivity of 95% and a specificity of 63% for differentiating severe from non-severe AR. In 
16% of patients AR grading was not possible due to feasibility problems. Similarly, 48 
patients with MR, predominantly as a consequence of valve prolapse, underwent CMR and a 
TTE. The algorithm showed a specificity of 86% and a specificity of 80% in differentiating 
between severe and non-severe MR, although it particularly was good rolling in severe MR. 
Furthermore, these studies demonstrated modest correlations between echocardiographic 
measures of regurgitation severity and CMR in both AR and MR, emphasizing the importance 
of the use of an integrative approach using both quantitative and qualitative measures when 
grading regurgitation severity. 
The usefulness of novel software able to automatically trace the MR continuous wave-
Doppler envelope and calculating the average pixel intensity (Figure 3) was studied in 112 
patients with mitral valve prolapse and MR. Acquisition was feasible in 89% of patients, 
demonstrated excellent reproducibility, and correlated well (r=0.90) with the effective 
regurgitation orifice area. The authors concluded that the method was fast, easy and 
reproducible and may have potential advantages over current MR severity assessment 
methods23. 
   
Congenital heart disease 
Adults with repaired coarctation have reduced life expectancy. Exercising such patients, Di 
Salvo et al.24 showed hypertension, residual pressure gradient, an increase in LV mass and 
decreased global longitudinal strain. 
Across the range of bicuspid aortic valve (BAV) phenotypes, Aguiar Rosa et al.25 reported 
flow in proximal aorta, aortic wall shear stress (WSS) and aortic valve shear stress.  The 
turbulent high velocity flow from a BAV generated a higher WSS, leading to aortic dilatation, 
with BAV morphology influencing aortopathy phenotype. 
Lesniak-Sobelga et al.26 reported on BAV during pregnancy in 96 women over a 19-year 
period. Fifty-six patients had AS and 40 patients had AR. During pregnancy, all patients with 
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mild AS remained in NYHA functional class I.  LV mass and aortic pressure gradients 
increased significantly with gestation but decreased after delivery. Volume overload of 
pregnancy is well tolerated in patients with mild/moderate AR, but complications increased 
with AR severity, LV enlargement, impaired systolic function and/or the enlargement of 
ascending aorta. 
 
Ivanac et al.27 reported from a single centre retrospective study of repaired tetralogy of Fallot 
(rToF) and pregnancy. Reassuringly, there was no change in NYHA class, LV size, strain and 
strain rate; RV global longitudinal strain rate, RV free wall strain and strain rate, RV FAC, 
RV S’, tricuspid regurgitation or pulmonary stenosis severity. 
Van De Brauene et al.28 examined right ventricular outflow tract to pulmonary artery (RVOT-
PA) anatomy with CMR in adults with repaired rToF. RVOT-PA dimensions and volumes are 
related to indexed RV volumes, RV mass and severity of pulmonary regurgitation (PR). 
RVOT-PA volumes were divided into straight, convergent, divergent, convex or concave 
morphologies (Figure 4). Patients with divergent RVOT-PA type may have worse NYHA 
class. 
In 85 patients with rToF, significant PR and RV dilatation (mean 150 mL/m2), and > 2 CMR 
exams during the study period (2002-2016), Hoelscher et al.29 reported that progression of RV 
dilatation is infrequent (23%) and slow and advised a conservative approach to pulmonary 
valve replacement. 
Aortic root dilatation (ARD) is frequent in rToF and may progress over time leading to 
complications including AR, aortic aneurysm and dissection.  In a single centre study, 
Grotenhuis et al.30 studied 768 children; 77% ToF, 5% Double Outlet RV (DORV)/ToF, 18% 
ToF/Pulmonary Atresia (PAT). The mean age at repair was 12.120.9 months. The aortic root 
was enlarged at diagnosis and during follow-up (6.3±2.2-years). The results showed a mean 
AoV annulus Z-score at first post-op echo of 3.32.7. The mean maximum AoV diameter Z-
score during follow-up was 4.32.7, with no significant progression of ARD during follow-
up. An increase in ARD at a rate >1 Z-score unit/year was observed in <1% of patients and 
the mean rate of Z-score change was -0.09 Z-score unit/year. Only 3/768 patients developed 
moderate or severe AR and 2 required aortic surgery. 
Michalek et al.31 reported neo-AR in 53 adults during late follow up (mean 20.5 years) after 
the Arterial Switch Operation for Transposition of the Great Arteries. TTE was used to grade 
NeoAR qualitatively compared to CMR severity grade based on regurgitant fraction.   Both 
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modalities correlate well at low grades, but TTE overestimates severity (P<0.001) at 
moderate-severe neo-AR. 
Intracardiac blood flow, WSS and energy loss (EL) using vector flow mapping and colour 
Doppler was reported in normal children32, and in children with hypertrophic cardiomyopathy 
(HCM) and dilated cardiomyopathy (DCM) Craft et al.33 Vector flow derived left ventricular 
diastolic indices in children are heart rate dependent and associated with E/e’.  In HCM/DCM, 
predominant EL was noted in systole for HCM, but in diastole for DCM and controls. Energy 
loss curves showed lower amplitudes in DCM compared to controls. 
 
Nuclear Cardiology and Cardiac Computed Tomography 
The evaluation of myocardial perfusion abnormalities for the detection of ischemia by SPECT 
or positron emission tomography (PET) is well established. On the contrary, CCTA is widely 
used for diagnosis of coronary artery disease. Oleksiak et al.34 showed that the evaluation of 
myocardial ischemia is feasible also by dynamic CCTA and may add diagnostic value in 
patients with anatomically intermediate coronary artery stenosis. To this purpose, they 
enrolled a series of 17 consecutive patients with intermediate stenosis detected by CCTA. 
Myocardial perfusion was evaluated at baseline and after vasodilation with regadenoson and 
compared to similar protocol obtained by CMR. The distribution of myocardial contrast agent 
in dynamic CCTA, was represented as quantitative parameters for each myocardial segment: 
myocardial blood flow (MBF), myocardial blood volume, peak value, time to peak, perfused 
capillary blood volume (Figure 5). The Authors concluded that in a multivariate model, MBF 
and peak value predicted myocardial ischemia with better accuracy compared to individual 
parameters. 
The CT could be used also for planning specific 3D-printing. Percutaneous left atrial 
appendage (LAA) occlusion has emerged as an alternative approach to medical therapy for 
stroke prevention in patients with atrial fibrillation. Guglielmo et al.35 evaluate whether the 
sizing of the implanted occluder device, based on the sole medical image analysis, was in 
accordance with the sizing obtained using the 3D printing mode. The final goal was to 
evaluate if the mismatch between two different approaches was correlated with adverse 
outcome, and if 3D printing could be a valuable tool to enhance the pre-operative sizing stage. 
The results, even if obtaining in a series of 13 patients evaluated retrospectively, were very 
encouraging. As a matter of fact, the results suggested that the use of 3D printing models help 
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in finding the correct size of the device, potentially avoiding the negative outcome of the 
surgery. 
The CT could also be used for identifying patients who benefit more from specific surgical 
treatment such as mitral valve repair. Solowjowa et al.36 investigated the possibility to 
optimize the surgical procedure for LV aneurysms using an algorithm based on CT 
assessment. In 30 consecutive patients, the mitral valve leaflets and apparatus were 
characterized and measured. The Authors analysed the surgically relevant differences between 
posterior and anterior localization, and the mid-term results of both groups. The obtained 
results suggested that the CT guided strategy for surgical valve repair of LV aneurysms could 
allow excellent mid-term results to be achieved due to adequate volume reduction and 
functional improvement. 
Stress myocardial perfusion SPECT is clinically used for cardiovascular risk assessment prior 
to kidney transplantation. Berlot et al.37 examined the predictive value of SPECT for coronary 
artery disease or perioperative and long-term cardiovascular events in a series of 80 
consecutive patients undergoing renal transplant. Sensitivity and specificity of SPECT in 
identifying significant perioperative cardiovascular risk were of 100% and 84%, respectively. 
Moreover, reversible ischemia emerged as an independent predictor of long-term 
cardiovascular events following transplant. Based on these data, SPECT should be used a 
useful modality for cardiovascular risk stratification and to predict long-term prognosis of 
patients undergoing kidney transplant. 
Holcman et al.38 compared 99mTc-HMPAO-SPECT/CT and TTE diagnostic value in 40 
consecutive patients with suspected infective endocarditis. Study included 6 months follow-
up, followed by outpatient visit and TTE. This study highlighted and confirmed the diagnostic 
value of 99mTc-HMPAO-SPECT/CT in assessing infective endocarditis suspicion. In patients 
with suspected infective endocarditis 99mTc-HMPAO-SPECT/CT provided higher specificity 
and positive predictive value than TTE. 
There is limited evidence regarding the comparison of vascular inflammation between 
subjects with familial combined hyperlipidaemia (FCH) and heterozygous familial 
hypercholesterolemia (heFH). Benetos et al.39 compared the degree of arterial inflammation as 
assessed by 18 F fluorodeoxyglucose PET (FDG-PET) in asymptomatic individuals with FCH 
and heFH (both n=14). Nondyslipidaemic individuals scheduled for FDG-PET imaging were 
used as control group (n=14).  
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Radiotracer uptake within the arterial wall was quantified as target to background ratio (TBR) 
along the aorta. Blood lipid profile, high sensitive C reactive protein (hs-CRP) and fibrinogen 
were obtained from all subjects. The obtained results indicated that FCH is associated with 
increased both systemic and vascular inflammation, compared to heFH.  
 
Cardiovascular magnetic resonance 
The CMR myocardial feature tracking (CMR-FT) is a novel post-processing method which is 
receiving increasing interest due to its accurate assessment of global circumferential (GCS), 
radial (GRS) and longitudinal (GLS) myocardial strain,  
The prognostic role of these novel functional parameters in the context of ischemic heart 
disease are not well established. Eitel et al.40 conducted a large multicentre study of patients 
with reperfused myocardial infarction (MI) (n=1235, 64% with ST-elevation MI, 36% with 
non ST-elevation MI) undergoing CMR with GLS, GRS, GCS measured by a central corelab.  
They demonstrated that GLS was the strongest strain parameter predicting future 
cardiovascular events, independently of traditional established prognostic markers. In 
particular, GLS provided an incremental prognostic value for all-cause mortality above LV 
ejection fraction and infarct size. Lange et al.41 investigated both the mechanistic and 
prognostic value of CMR-FT in 152 patients with Tako-Tsubo cardiomyopathy with varying 
type of LV apical ballooning (apical 72%, mid-ventricular 26.7% and basal 1.3%) compared 
to 20 healthy control subjects and to 20 patients with Tako-Tsubo rescanned at 3-month 
follow up. They measured systolic torsion, diastolic recoil and dyssynchrony by the means of 
circumferential and radial uniformity ratio estimates. They observed that dyssychrony is a 
distinct feature of acute Tako-Tsubo cardiomyopathy, that it is more prominent in the apical 
than in the midventricular ballooning and that resolves in parallel with the systolic function. 
Additionally, they demonstrated that higher degree of dyssynchrony is associated with 
impaired rotational mechanics, and that diastolic recoil identifies a subgroup of patients at 
high mortality risk characterized by highly impaired rotational mechanics (Figure 6). In 
conclusion, whilst transient circumferential dyssynchrony is a distinct feature in the acute 
phase, mechanical rotational performance remains impaired and predicts adverse cardiac 
events. There is also limited evidence on the role of CMR-FT in the context of valvular heart 
disease. Gonzales-Gomez et al.42 performed a RV volumetric and deformation analysis in 13 
patients with asymptomatic severe tricuspid regurgitation compared to 10 healthy controls. 
Despite normal and comparable RVEF and RV volumes between the 2 groups, patients with 
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severe tricuspid regurgitation showed impaired longitudinal and radial RV strain values 
compared to control. This study suggests a promising role of RV CMR-FT as an early marker 
of RV systolic dysfunction before RVEF declines and volumes increase.  Hwang et al.43 used 
CMR-FT and CMR T1 mapping to predict LV reverse remodeling in 63 patients with severe 
aortic stenosis before surgical aortic valve replacement. They demonstrated that strain 
parameters measured by CMR-FT correlated with the amount of myocardial fibrosis (native 
T1 mapping and interstitial fibrosis, ECV), and that reverse remodeling significantly 
correlated with myocardial strain with GLS independently predicting LV mass index 
regression.  
Finally, Gertz et al.44 proposed an important methodological piece of work of assessing inter-
vendor agreement of LV/RV myocardial feature tracking. They evaluated patients with 
normal and abnormal LV/RV systolic function (10 patients in each group), and images were 
analysed in the long-and short-axis views using 2 different software vendors. They concluded 
that GCS and LV GLS are the most robust parameters within and between softwares, whilst 
GRS and RV GLS show high inter-vendor variability but with an improved and acceptable 
reproducibility using each software when performing repeated analyses. Intra-vendor 
reproducibility was excellent for GCS, LV GLS and RV GLS, but lower for GRS. 
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Figures Legend 
 
Figure 1: Left ventricular mechanical dispersion (left mid panel) and right ventricular 
longitudinal strain (left lower panel) were strong predictors of ventricular arrhythmias in 
patients with arrhythmogenic cardiomyopathy. 
Figure 2: Kaplan-Meier survival curves, showing the value of left ventricular mechanical 
dispersion (MD) 56 ms to predict survival free of significant arrhythmias in whole cohort 
(left) and in patients with left ventricular ejection fraction 35% (right). 
Figure 3: Tracing of the continuous wave-Doppler mitral regurgitation envelope and 
calculating the average pixel intensity (left panel). The software identifies the numbers of 
pixels and the pixel intensity and calculates the average pixel intensity in a non-holosystolic 
(right upper panel) and holosystolic. 
Figure 4: Representative figure of the 5 distinct configurations (convergent, divergent, 
straight, convex or concave) based on 3 measurements (proximal, distal and mid RVOT-PA) 
using previously applied mathematical modelling. 
Figure 5: CCTA revealed intermediate LAD stenosis (Panel A and B). Dynamic CCTA with 
perfusion defect (Panel C and D). 
Figure 6: Short axis (SA) views of the left ventricle in a patient with Takotsubo syndrome 
with typical apical ballooning. Tracked endo- and epicardial borders are being displayed in 
apical, midventricular and basal SA views (left panels) with plotted rotation and torsion over a 
single cardiac cycle (right panel). 
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